Loading provider…
Loading provider…
Radiation Oncology Physician in Louisville, KY
NPI: 1114983871Primary Practice Location
BAPTIST HEALTH LOUISVILLE
4000 Kresge Way, Louisville, KY
Primary Employer
Norton Cancer Institute
nortonhealthcare.com
HQ Phone
Get MD PHD Aaron's Phone Numberphone_androidMobile
Get MD PHD Aaron's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77334Design and construction of complex radiation treatment device | 129 | 497 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 126 | 167 |
| 3 | 77263Complex radiation therapy planning | 122 | 141 |
| 4 | 77300Calculation of radiation therapy dose | 112 | 513 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 99 | 99 |
Improvement of therapeutic index for brain tumors with daily image guidance.
Guidelines for treatment naming in radiation oncology.
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy Procedure, RADIATION: Image Guided Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Cetuximab, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, BIOLOGICAL: Durvalumab
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: 3-Dimensional Conformal Radiation Therapy, RADIATION: Proton Beam Radiation Therapy, RADIATION: Photon Beam Radiation Therapy